Pramipex (Pramipexole Tablets) is a dopamine agonist used to manage symptoms of Parkinson’s disease and Restless Legs Syndrome (RLS). It mimics the action of dopamine in the brain, helping improve muscle control, reduce tremors, and restore smoother movement. Pramipex is highly effective for reducing stiffness, shakiness, and the urge to move limbs at night.
Recommended as both standalone and adjunct therapy, Pramipex brings relief to those experiencing motor complications and sleep disturbances related to dopamine imbalance.
Select options
This product has multiple variants. The options may be chosen on the product page
Rasalect (Rasagiline) is a selective MAO-B inhibitor used for the treatment of Parkinson’s disease. It helps increase dopamine levels in the brain, thereby improving motor symptoms such as stiffness, tremors, and slowness of movement. Rasalect is used both as monotherapy in early Parkinson’s and in combination with other medications like levodopa during later stages.
With regular use, Rasalect helps slow disease progression, improve mobility, and reduce “off” time in patients with fluctuating symptoms.
Select options
This product has multiple variants. The options may be chosen on the product page
Syndopa 110 Tablet combines a carefully balanced dose of levodopa and carbidopa to manage the motor symptoms of Parkinson’s disease. By converting to dopamine in the brain, levodopa relieves tremors, stiffness, and slowness, while carbidopa prevents premature peripheral breakdown of levodopa for better efficacy. Ideal for patients seeking consistent symptom control.
Select options
This product has multiple variants. The options may be chosen on the product page
Syndopa 275 Tablet is a high-strength combination of levodopa and carbidopa designed to manage moderate-to-severe Parkinson’s disease symptoms. Levodopa helps replenish dopamine levels in the brain to reduce tremors, rigidity, and bradykinesia, while carbidopa enhances its effectiveness by preventing early breakdown, resulting in more stable symptom relief.
Select options
This product has multiple variants. The options may be chosen on the product page
Syndopa CR 250 Tablet is a controlled‑release formulation combining levodopa with carbidopa to offer prolonged symptom control in Parkinson’s patients. By gradually releasing medication over 8–12 hours, Syndopa CR helps maintain consistent dopamine levels to reduce tremors, rigidity, and “off” episodes. Ideal for patients needing smoother motor function throughout the day and night.
Select options
This product has multiple variants. The options may be chosen on the product page
Syndopa Plus Tablet combines levodopa and carbidopa with entacapone to provide enhanced and sustained control of Parkinson’s motor symptoms. Levodopa increases dopamine levels, carbidopa improves its efficacy, and entacapone extends activity duration by inhibiting dopamine breakdown. This triple-therapy ensures longer “on” periods, smoother movement, and reduced “wearing‑off” episodes for better daily control.
Select options
This product has multiple variants. The options may be chosen on the product page
End of content
End of content
Join our newsletter and get 50% off your first order
Subscribe to our newsletter and get the latest trending products and offers updates.
Wait! before you leave…
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.
